Core Viewpoint - The legal opinion issued by Zhejiang Tian Ce Law Firm confirms that Shanying International Holdings Co., Ltd. is qualified to implement its 2025 Employee Stock Ownership Plan (ESOP) in compliance with relevant laws and regulations [1][12]. Group 1: Company Qualification - Shanying International is a legally established joint-stock company under Chinese law, with its shares listed on the Shanghai Stock Exchange [2][4]. - The company holds a valid business license issued by the Market Supervision Administration of Ma'anshan City, with a registered capital of 4,470,565,176.00 yuan [2][4]. Group 2: Legality and Compliance of the ESOP - The law firm conducted a thorough review of the ESOP and confirmed that it adheres to the "Guiding Opinions" issued by the China Securities Regulatory Commission [5][12]. - The ESOP is based on voluntary participation, with no forced allocation of shares to employees, aligning with the principle of voluntary participation [5][12]. - The plan ensures that employees bear their own risks and that their rights are equal to other investors, complying with the risk-bearing principle [5][12]. Group 3: Legal Procedures for the ESOP - Shanying International has followed necessary legal procedures, including holding a staff representative meeting and board meeting to approve the ESOP draft [10][11]. - The company has disclosed relevant resolutions and opinions on designated information disclosure websites, fulfilling its information disclosure obligations [11][12]. Group 4: Information Disclosure - The company has announced the resolutions from the staff representative meeting, board meeting, and the ESOP draft on the designated information disclosure website, meeting the required disclosure obligations [12].

券法》"）、《关于上市公司实施员工持股计划试点的指导意见》（以下简称"《指 导意见》"）《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》（以下简称"《自律监管指引》"）等相关法律、法规及规范性文件和《南亚 新材料科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，对公 司《2025 年员工持股计划（草案）》（以下简称"《持股计划（草案）》"）进行了 核查，发表核查意见如下： 规定的禁止实施员工持股计划的情形；《持股计划（草案）》的内容符合《公司 法》、《证券法》《指导意见》《自律监管指引》等有关法律、法规及规范性文 件以及《公司章程》的规定，不存在损害公司及全体股东利益的情形。 引》及其他法律、法规、规范性文件规定的条件，符合本次员工持股计划规定的 参加对象的确定标准，其作为本次员工持股计划持有人的主体资格合法、有效， 亦不存在摊派、强行分配等方式强制员工参与本次员工持股计划的情形；公司不 存在向本次员工持股计划持有人提供贷款、贷款担保或任何其他财务资助的计划 或安排。 南亚新材料科技股份有限公司监事会 关于公司 2025 年员工持股计划（草案）的 核查意见 南亚新材料科技股份有 ...

Group 1 - The company announced the completion of the second lock-up period for its employee stock ownership plan, with the conditions for unlocking being met [1][3][6] - The total number of shares that can be attributed to the first grant of the employee stock ownership plan during the second lock-up period is 450,000 shares, which accounts for 0.13% of the company's total share capital [4][7] - The company achieved a net profit of 317,153,320.62 yuan for 2024, surpassing the performance target of 306 million yuan, resulting in a company-level attribution coefficient of 100% [6][8] Group 2 - The employee stock ownership plan consists of three phases of vesting, with the second phase's shares being unlocked after 24 months [5] - The personal performance assessment for the stock ownership plan resulted in 11 out of 13 participants achieving a performance level of "B" or above, allowing for full unlocking of their shares [7] - The company will adhere to market trading rules and regulations regarding stock trading during sensitive periods [8][9]

Core Viewpoint - The announcement details the completion and termination of the 2022 Employee Stock Ownership Plan (ESOP) of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd, highlighting the acquisition of shares by the company's general manager and board member Wang Ke, reflecting confidence in the company's future development [1][5]. Group 1: Share Acquisition Details - Wang Ke acquired 22 million shares through block trading, representing 1.72% of the company's total share capital [3][4]. - Prior to the acquisition, Wang Ke held 63,409,600 shares, which was 4.95% of the total share capital [2][4]. - After the acquisition, Wang Ke's total shareholding increased to 85,409,600 shares, or 6.67% of the total share capital [4]. Group 2: Employee Stock Ownership Plan - The 2022 ESOP was approved in August 2022, with 30 million shares transferred to the plan's dedicated account at a price of 4.83 yuan per share, totaling 144.9 million yuan [5][6]. - The lock-up period for the ESOP ended on September 5, 2023, and the plan was extended for an additional 12 months in August 2024 [6]. - As of June 25, 2025, all shares held under the ESOP were sold, with 22 million shares sold to Wang Ke and the remaining 8 million shares sold through centralized bidding [6][7]. Group 3: Compliance and Governance - The share acquisition complies with relevant laws and regulations, ensuring that the company's shareholding structure remains within listing requirements [4][6]. - The acquisition is expected to enhance the company's governance structure and stabilize management control, reflecting the management's confidence in the company's long-term value [4][6].

Core Viewpoint - The article discusses the challenges faced by Laiyifen, a leading snack company in China, particularly regarding its employee stock ownership plans and financial performance, while also highlighting the competitive landscape in the snack industry. Group 1: Employee Stock Ownership Plans - Laiyifen completed a share buyback plan, repurchasing 2.9054 million shares for a total of 30.2236 million yuan, intended for an employee stock ownership plan [1] - The company faced setbacks with its employee stock ownership plans, having previously failed to meet performance targets in 2022 and terminating its second plan in 2024 due to poor financial results [2][3] - The second plan's performance criteria were adjusted to a 3% revenue increase or a 20% net profit increase, but the company reported a 15.25% decline in revenue and a net loss of 75.27 million yuan for the year [2] Group 2: Financial Performance - In 2024, Laiyifen's revenue was 3.37 billion yuan, down 15.25% year-on-year, and it reported a net loss of 7.527 million yuan, marking a second consecutive year of declining revenue and profit [2] - The company's first quarter of 2024 saw revenue of 1.048 billion yuan, a decrease of 1.23%, and a net profit of 12.43 million yuan, down nearly 80% year-on-year [2] - Laiyifen's gross margin for 2024 was reported at 38.82%, the highest in the industry, exceeding the average by nearly 8 percentage points [6][7] Group 3: Competitive Landscape - The snack industry is witnessing a rise in volume snack brands, with companies like Mingming Hen Mang achieving significant growth, reporting 39.344 billion yuan in revenue and a net profit of 0.913 billion yuan in 2024 [5] - Laiyifen's management indicated that they would maintain strategic focus and not enter the volume snack market, despite the competitive pressure [6] - Other companies in the industry, such as Three Squirrels and Salted Fish, have successfully implemented employee stock ownership plans, while others like Good Idea and Qiaqia Foods have faced challenges [3][5] Group 4: Quality Control and Safety Issues - Laiyifen faced a food safety crisis when a consumer reported finding a foreign object in a product, prompting the company to initiate an internal investigation [10] - The company utilizes an outsourcing model for production, which poses challenges for quality control, necessitating a robust quality management system [11] - Laiyifen has implemented a comprehensive quality control system, including supplier selection and regular inspections, to mitigate risks associated with its outsourcing strategy [11]

Group 1 - The recent "Super League" trend is expanding from professional sports to listed companies, exemplified by Goer Group's successful first global employee football league [1] - Goer Group launched the "Together Goal" football league in May, inviting 80,000 global employees, with 35 teams and over 700 participants [1] - The company has a strong football culture, established since 2010, and the recent event saw participation from various employee roles, enhancing team spirit and cultural values [1][2] Group 2 - Goer Group's mission is to create health and beauty through technology, promoting a culture of collaboration and growth among employees [2] - The recent football event provided a platform for employees from different countries and departments to unite towards a common goal, embodying the company's cultural spirit [2] - Goer Group announced the "Home 8" employee stock ownership plan, involving up to 1,130 participants and a holding size of no more than 52.32 million shares, representing 1.5% of the total share capital [2] Group 3 - Goer Group is implementing a dual-driven strategy of intelligent and precision manufacturing, focusing on precision components, intelligent systems, and content services [3] - The demand for acoustic and microelectronic components in consumer electronics is increasing, driven by AI, leading to a rise in TWS earphone shipments and expanding XR glasses client base [3] - Analysts predict that by continuously building an AI industrial ecosystem, Goer Group's new terminal product shipments and product structure optimization will further improve [3]

Core Viewpoint - The company is announcing the upcoming expiration of its ninth employee stock ownership plan, which is set to end on December 24, 2025, and outlines the plan's details and future arrangements [1][2][3]. Summary by Sections Employee Stock Ownership Plan Status - The ninth employee stock ownership plan has acquired a total of 2,701,000 shares through market transactions, representing 0.53% of the company's total share capital [2]. Future Arrangements - After the lock-up period ends, the management committee will decide on the sale of the corresponding shares and the distribution of profits, if any, after deducting relevant taxes [2][3]. Compliance and Regulations - The plan will adhere to market trading rules and regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange regarding sensitive periods for trading [3]. Duration and Modifications - The plan's duration is set for 24 months, starting from December 25, 2023, to December 24, 2025. Changes to the plan require approval from two-thirds of the participating shareholders [3][4].

Core Points - The company is holding its second extraordinary general meeting of shareholders on July 2, 2025, to discuss important resolutions [1][2] - The meeting will combine on-site voting and online voting, with each share carrying one vote [2][3] - The company has proposed an employee stock ownership plan for 2025, which requires shareholder approval [3][4] Meeting Procedures - The meeting will be presided over by the chairman, Mr. Jiang Xipei, and will include a sign-in process, announcement of attendees, and reading of proposals [2] - Shareholders have the right to speak, inquire, and vote, while also being required to adhere to meeting discipline [1][2] - The voting process will be supervised by two shareholder representatives, a supervisor, and a lawyer from Guohao Law Firm [2] Proposed Resolutions - The first resolution involves the approval of the 2025 first phase employee stock ownership plan and its summary [3] - The second resolution pertains to the management measures for the 2025 first phase employee stock ownership plan [3] - The third resolution seeks authorization for the board of directors to handle matters related to the employee stock ownership plan [3][4]

国浩律师（上海）事务所 关于 远东智慧能源股份有限公司 之 法律意见书 上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编：200085 电话/Tel: (+86)(21) 5234 1668 传真/Fax: (+86)(21) 5234 1670 网址/Website: http://www.grandall.com.cn 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于远东智慧能源股份有限公司 之法律意见书 致：远东智慧能源股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受远东智慧能源股份有限公 司（以下简称"远东股份"或"公司"）的委托，担任公司 2025 年第一期员工持股 计划（以下简称"本次员工持股计划"）的专项法律顾问。 本所律师根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中 华人民共和国公司法》（以下简称"《公司法》"）、《关于上市公司实施员工持 股计划试点的指导意见》（以下简称"《试点指导意见》"）、《上海证券交易所 上市公司自律监管指引第 1 号——规范运作》（以下简称"《自律监管指引》"） 等法律、法规和中国证券监督管理委员会（以下简称" ...

证券代码：688739 证券简称：成大生物 公告编号：2025-035 辽宁成大生物股份有限公司 关于回购股份事项前十大股东和前十大无限售条件股东 持股情况的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 辽宁成大生物股份有限公司（以下简称"公司"）于 2025 年 6 月 19 日召开第五 届董事会第十九次会议，审议通过了《关于以集中竞价交易方式回购公司股份方案的 议案》，同意公司使用部分超募资金以集中竞价交易方式回购公司人民币普通股（A 股）股份用于实施股权激励或员工持股计划。具体内容请详见公司于 2025 年 6 月 20 日在上海证券交易所网站（www.sse.com.cn）披露的《辽宁成大生物股份有限公司关 于以集中竞价交易方式回购公司股份的回购报告书》（公告编号：2025-034）。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，现将公司董事会公告股份回购方案决议前一个交易日 （2025 年 6 月 19 日）登记在册的前十大股东和前十大无限售条件股东的 ...